September 01, 2023

Discontinuation of Flovent HFA and Flovent Diskus

Last modified: Sept. 9, 2023

Updated the QVAR Redihaler® effective coverage Oct. 1, 2023 as noted in footnote 2

View alternative covered options

Drug manufacturer GlaxoSmithKline (GSK) recently notified the U.S. Food and Drug Administration (FDA) that they would be discontinuing 2 of their brand products, Flovent Diskus and Flovent HFA. According to the announcement, the last date these products will be available for ordering is Dec. 31, 2023.

Preferred covered alternatives

We have identified preferred covered alternatives to help ensure your UnitedHealthcare patients continue to have access to a covered inhaled corticosteroid to treat their respiratory conditions.

Refer to the table below to determine if any of the preferred covered alternatives are suitable options. You can also use PreCheck MyScript via most “electronic medical records’ real-time benefit check functionality” or the UnitedHealthcare Provider Portal to view other covered alternatives.

UnitedHealthcare plan Preferred covered inhaled corticosteroids
UnitedHealthcare commercial plans Arnuity Ellipta and QVAR Redihaler®
Individual Exchange plans, also referred to as UnitedHealthcare Individual and Family ACA Marketplace plans

Select states (CO, KS, MD, MI, MO, MS, OK, TN, TX, WA)

Arnuity Ellipta, Pulmicort Flexhaler, QVAR Redihaler®

All other states: Arnuity Ellipta, Asmanex® HFA, Asmanex® Twisthaler®, Pulmicort Flexhaler, QVAR Redihaler®

UnitedHealthcare Community plans View state-specific drug lists for preferred covered medications
Individual UnitedHealthcare® Medicare Advantage and stand-alone Part D plans 

For plans that currently cover Flovent: Arnuity Ellipta and QVAR Redihaler®2

For plans that currently do not cover Flovent: Pulmicort Flexhaler, ArmonAir® Digihaler®


Send us a message or chat with a live advocate 7 a.m.–7 p.m. CT from the Contact Us page. 

1QVAR Redihaler® will be brought into coverage Jan. 1, 2024, for UnitedHealthcare commercial plans and the Flovent products will be excluded.
2 QVAR Redihaler® will be brought into coverage Oct. 1, 2023, for Individual UnitedHealthcare® Medicare Advantage and standalone Part D plans that currently cover Flovent and Flovent products will be covered until no longer commercially available.
Finding news icon

Discover more news

Personalized news icon

Get personalized news